368 related articles for article (PubMed ID: 12858078)
1. Statins as potential therapeutic agents in neuroinflammatory disorders.
Stüve O; Youssef S; Steinman L; Zamvil SS
Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
[TBL] [Abstract][Full Text] [Related]
2. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
3. Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins.
Schmeer C; Kretz A; Isenmann S
Restor Neurol Neurosci; 2006; 24(2):79-95. PubMed ID: 16720944
[TBL] [Abstract][Full Text] [Related]
4. Statins--a cure-all for the brain?
Menge T; Hartung HP; Stüve O
Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Kuipers HF; van den Elsen PJ
Biomed Pharmacother; 2007 Aug; 61(7):400-7. PubMed ID: 17643927
[TBL] [Abstract][Full Text] [Related]
6. Drug Insight: using statins to treat neuroinflammatory disease.
Weber MS; Prod'homme T; Steinman L; Zamvil SS
Nat Clin Pract Neurol; 2005 Dec; 1(2):106-12. PubMed ID: 16932506
[TBL] [Abstract][Full Text] [Related]
7. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms underlying the effects of statins in the central nervous system.
McFarland AJ; Anoopkumar-Dukie S; Arora DS; Grant GD; McDermott CM; Perkins AV; Davey AK
Int J Mol Sci; 2014 Nov; 15(11):20607-37. PubMed ID: 25391045
[TBL] [Abstract][Full Text] [Related]
9. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
Neuhaus O; Stüve O; Archelos JJ; Hartung HP
J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of statins.
Stepień K; Tomaszewski M; Czuczwar SJ
Pharmacol Rep; 2005; 57(5):561-9. PubMed ID: 16227638
[TBL] [Abstract][Full Text] [Related]
11. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic role of statins in neurological disorders.
Bifulco M; Malfitano AM; Marasco G
Expert Rev Neurother; 2008 May; 8(5):827-37. PubMed ID: 18457539
[TBL] [Abstract][Full Text] [Related]
13. Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?
Steffens S; Mach F
Nat Clin Pract Nephrol; 2006 Jul; 2(7):378-87. PubMed ID: 16932466
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory properties of statins.
Steffens S; Mach F
Semin Vasc Med; 2004 Nov; 4(4):417-22. PubMed ID: 15861323
[TBL] [Abstract][Full Text] [Related]
15. Statins: mechanisms of neuroprotection.
van der Most PJ; Dolga AM; Nijholt IM; Luiten PG; Eisel UL
Prog Neurobiol; 2009 May; 88(1):64-75. PubMed ID: 19428962
[TBL] [Abstract][Full Text] [Related]
16. Role of statins in the treatment of multiple sclerosis.
Ciurleo R; Bramanti P; Marino S
Pharmacol Res; 2014 Sep; 87():133-43. PubMed ID: 24657241
[TBL] [Abstract][Full Text] [Related]
17. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
18. Statins in nervous system-associated diseases: angels or devils?
Lei Q; Peng WN; You H; Hu ZP; Lu W
Pharmazie; 2014 Jun; 69(6):448-54. PubMed ID: 24974580
[TBL] [Abstract][Full Text] [Related]
19. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
Miida T; Takahashi A; Ikeuchi T
Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
[TBL] [Abstract][Full Text] [Related]
20. Impact of HMG-CoA reductase inhibition on brain pathology.
Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
